This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Memorial Sloan Kettering Cancer Center, New York University, Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana (Fisabio). Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 618 
2 out of 1,727 
1 out of 3 Years Active: 2018-2019
Title: Carles Ubeda: Innovator in Psoriatic Arthritis Treatment
Introduction
Carles Ubeda is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of medical research, particularly in the treatment of psoriatic arthritis and rheumatoid arthritis. With a total of 2 patents, Ubeda's work is paving the way for advancements in therapeutic methods.
Latest Patents
Ubeda's latest patents include innovative methods for treating psoriatic arthritis. These patents encompass methods, agents, and compositions aimed at effectively managing this condition. Additionally, he has developed diagnostic methods related to rheumatoid arthritis. His work includes methods, reagents, and compositions for predicting the onset of rheumatoid arthritis in susceptible individuals, diagnosing its onset, and evaluating the efficacy of therapeutic regimens. Notably, he has identified specific bacterial species as biomarkers for these conditions.
Career Highlights
Throughout his career, Ubeda has worked with prestigious institutions such as New York University and Memorial Sloan Kettering Cancer Center. His research has focused on developing new therapeutic approaches and enhancing diagnostic capabilities in the field of rheumatology.
Collaborations
Ubeda has collaborated with esteemed colleagues, including Jose U Scher and Dan R Littman. These partnerships have further enriched his research and contributed to the advancement of medical science.
Conclusion
Carles Ubeda's innovative work in the treatment of psoriatic arthritis and rheumatoid arthritis highlights his commitment to improving patient outcomes. His contributions to medical research are invaluable and continue to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile